| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 21.30 | 0.23 (+1.09%) | 15.97 - 21.30 | 0.0 |
Market data as of 6:06PM 05/17/13. Quotes are delayed by at least 15 min.
The investment seeks long-term growth of capital. The fund's principal investment strategy is based on value. The value oriented philosophy to which the fund subscribes is that of investing in securities believed to be undervalued in the market. The adviser selects securities through extensive quantitative research, which includes the use of a multi-factor model that the adviser employs to identify and rank companies within the Russell 3000 Value Index. It employs a strategy to hold securities between its annual rebalancings, even if there are adverse developments concerning a particular security, an industry, the economy or the stock market generally.
| Total Return | 7.32% |
|---|---|
| Yield (Trailing 12 Mo.) | 1.20% |
| Expense Ratio | 1.49% |
| Front Load | 5.75% |
| Deferred Load | None |
| Minimum Investment | $500.00 |
| Management Tenure | 2 Years |
| Fund Inception | 11/01/1999 |
| Timeframe | SFVAX | S&P 500 | Large Blend |
|---|---|---|---|
| 1 Month | 0.35% | 1.93% | 1.69% |
| 3 Month | 6.74% | 7.18% | 6.59% |
| Year-to-Date | 12.61% | 12.74% | 12.31% |
| 1 Year | 18.36% | 16.89% | 15.95% |
| 3 Year | 10.13% | 12.80% | 11.00% |
| 5 Year | 2.03% | 5.21% | 4.18% |
| 10 Year | 7.67% | 7.88% | 7.49% |
| Since Inception | 7.32% | 10.38% | -- |
| Basic Materials | 4.74% | |
|---|---|---|
| Consumer Cyclical | 11.48% | |
| Financial Services | 24.48% | |
| Real Estate | 0.00% | |
| Consumer Defensive | 8.95% | |
| Healthcare | 10.81% | |
| Utilities | 2.43% | |
| Communication Services | 2.86% | |
| Energy | 12.23% | |
| Industrials | 13.22% | |
| Technology | 8.81% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 97.53 | 97.53 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.00 | 0.00 | ||
| Foreign Stock | -- | 1.39 | 1.39 | ||
| Foreign Bond | -- | 0.00 | 0.00 | ||
| Total | -- | 98.92 | 98.92 | ||
| Cash | -- | 1.09 | 1.09 | ||
| Total Net Assets | $167.67M |
|---|---|
| Total Stock Holdings | 99 |
| Total Bond Holdings | 0 |
| Valuation | SFVAX | Category Range |
|---|---|---|
| Price/Earnings | 13.48 | |
| Price/Book | 1.62 | |
| Price/Sales | 1.12 | |
| Price/Cash Flow | 7.80 | |
| Dividend Yield | 2.79 | |
| LT Earnings | 9.5 | |
| Historical Earnings | 13.79 | |
| Sales Growth | -0.97 | |
| Cash-Flow Growth | 5.86 | |
| Book-Value Growth | 4.72 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Below Avg |
| Pretax Return | 10.13% |
|---|---|
| Tax-adjusted Return | 7.79% |
| Tax Cost Ratio | 0.17% |
| Potential Cap Gains | -62.62% |
